Skip to main content
EXO-ALV • RESEARCH USE ONLY

Alveolar Type 2 Exosomes

Exosomes secreted by lung alveolar type 2 cells, rich in surfactant proteins and anti-fibrotic mediators.

Product image for an exosome product from Akira Biotech
Surfactant-rich EVs
AT2 LINEAGE CARGO
— Secreted by alveolar type 2 cells and enriched for surfactant proteins plus anti-fibrotic mediators that stabilize distal airspaces.
Immune tone · matrix
PULMONARY MICROENVIRONMENT
— Modulates resident immune responses while steering parenchymal matrix turnover away from progressive fibrosis.
COPD · PF · ARDS
INDICATION MAP
— Covers obstructive and restrictive injury states, ARDS recovery, post-viral lung damage, and adjunct themes in asthma and cystic fibrosis research.
ROUTES, FORMATS & APPLICATIONS
Routes
TBATBA
Quantities
400 Billion Exosomes1ml
Potential Applications

These are experimental use cases, provided as a scientific reference for researchers. Except where noted, they did not use Akira Biotech materials, and results may not be reproducible with ours. Akira Biotech supplies laboratory reagents for research use only. Our products are NOT approved by FDA or any regulatory authority and are not for use in or on humans.

  • Chronic Obstructive Pulmonary Disease (COPD)
  • Pulmonary Fibrosis
  • Acute Respiratory Distress Syndrome (ARDS)
  • Post-COVID Lung Damage
  • Asthma
  • Cystic Fibrosis
  • Pulmonary Hypertension
  • Neonatal RDS
  • Lung Transplant Support

Compliance · Exosomes

cGMP manufacturing & cryopreservation

Cells are manufactured under cGMP conditions and cryopreserved using a non-toxic, glucose-based method with greater than 98% viability.

cGMPNON-TOXIC CRYOPRESERVATION>98% VIABILITY
Viability & cryopreservation

Cryopreserved using a non-toxic, glucose-based method with greater than 98% viability.

GLUCOSE-BASED CRYO>98% VIABILITY

Explore More

Keep browsing our product lineup